(Q91127283)

English

Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma

scientific article published on 22 August 2018

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit